Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Cheddar Quick Hit GSTV of January 18th
Cheddar Quick Hit GSTV
Jury Selection Begins in Investor Lawsuit Against Elon Musk
Long before beleaguered billionaire Elon Musk purchased Twitter in October, he had set his sights on Tesla, the electric automaker where he serves as CEO and from which he derives most of his wealth and fame.
Cheddar Afternoon News Briefings of January 17th
Cheddar Afternoon News Briefings
Afternoon Alexa Flash Briefings of January 17th
Alexa Flash Briefings
Judge Shuts Down Class Action Suit Against Twitter
Judge Shuts Down Class Action Suit Against Twitter
Stocks Closed Mixed on Wall Street in Uneven Trading
Major U.S. indexes closed mixed on Wall Street at the beginning of a holiday-shortened, but earnings-heavy week.
Market Minute: Bitcoin Rallies, TikTok Reveals Transparency Plan & EV Sales Surge
Here is a rundown of Cheddar News' top market stories of the day.
Global Slowdown, War, Climate Change on Tap at Davos
The winter meetup of CEOs and heads of state is the first since 2020.
8K Projectors and Smell-O-Vision: How We’ll Be Watching in the Near Future
The future of viewing is here, and it’s being projected into your living room.
